Figure S4 from In Situ Vaccination, Low-Dose Targeted Radionuclide Therapy, and Immune Checkpoint Inhibition Eradicate Poorly Immunogenic Metastatic Tumors in Murine Cancer Models
Year: 2026
Type: other
Abstract: MHC-1 is expressed on tumor cells after TRT+DCP+ISV.
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: gold
OpenAlex ID: W7205007591
Cites:
Cited by:
Related to:
